Home › Funds › Stolper Co › CVS
Stolper Co position in CVS
CVS HEALTH CORP · Consumer Staples
Stolper Co reported holding 27,753 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 0.63% of its reported portfolio and ranking #49 among its reported holdings. Stolper Co has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Stolper Co's CVS position evolved
Stolper Co first disclosed a stake in CVS in Q3 2023 at 23,103 shares (US$1.6M). The position peaked in Q1 2026 at 105,571 shares, worth US$8.0M. Across 13 filings, Stolper Co increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 27,753 shares valued at US$2.4M — an increase of 149 shares quarter over quarter.. Notable position changes include a 294% increase in Q1 2026 (shares rose 45% over the following quarter), a 74% trim in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 23.10K | $1.61M | New |
| Q4 2023 | 22.35K | $1.76M | Reduce |
| Q1 2024 | 23.20K | $1.85M | Add |
| Q2 2024 | 23.72K | $1.40M | Add |
| Q3 2024 | 23.87K | $1.50M | Add |
| Q4 2024 | 21.43K | $962.00K | Reduce |
| Q1 2025 | 24.80K | $1.68M | Add |
| Q2 2025 | 24.82K | $1.71M | Hold |
| Q3 2025 | 25.88K | $1.95M | Add |
| Q4 2025 | 26.81K | $2.13M | Add |
| Q1 2026 | 105.57K | $8.03M | Add |
| Q2 2026 | 27.60K | $2.86M | Reduce |
| Q3 2026 | 27.75K | $2.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Stolper Co
FAQ
How long has Stolper Co held CVS?
Stolper Co has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Stolper Co's current position in CVS?
As of Q3 2026, Stolper Co holds 27.75K shares of CVS (CVS HEALTH CORP), valued at $2.38M, representing 0.63% of its reported portfolio and ranking #49.
Has Stolper Co been buying or selling CVS?
In the latest 13F filing (Q3 2026), Stolper Co increased its position in CVS. The position peaked in Q1 2026 at 105.57K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.